Eve Technologies Corporation is a CLIA certified High Complexity International Laboratory.
Eve Technologies is certified by Centers for Medicare & Medicaid Services (CMS) as a High Complexity International Laboratory under the Clinical Laboratory Improvement Amendments (CLIA); specialty Diagnostic Immunology, subspeciality General Immunology. These are Laboratory Developed Tests (LDT) and do not appear on the lists of tests in the Federal Register and have not been reviewed by the U.S. Food and Drug Administration.
Clinicians: Check with your State Agency to see if additional Licensure/Registration requirements may apply.
Include a completed requisition form for each sample in the shipment to avoid delays in sample processing.
Download Our Requisition FormSelect your tests and place an online order. You will receive an invoice for credit card payment.
Select Your Tests and Place an Online OrderEve Technologies Corporation
Shipping/Receiving:
3415 A – 3 Ave., N. W.
Calgary, AB. Canada T2N 0M4
Indications: Use this test when identifying relevant therapy targets, mechanism of disease is unknown, arthritis, macrophage activation syndrome (MAS), Hemophagocytic lymphohistiocytosis (HLH), sepsis / toxic shock, necrotizing fasciitis, admitted meningitis, admitted pneumonia, Kawasaki syndrome, prolonged or periodic fever, severe or chronic inflammation, organ dysfunction. Also useful in investigation of ‘cytokine storm’ seen in COVID19. Essential for assessing Cytokine Release Syndrome (CRS), a critical condition resulting from the intense immune activation triggered by CAR-T cell therapy.
For more information on indications, cytokine clustering, and additional details, please visit this webpage.
Reference intervals available for PLASMA-EDTA, SERUM, and CSF samples.
Results provided with cytokine groupings (immune signatures).
Indications: Use this test to identify relevant therapy targets, determine disease mechanisms, and diagnose or monitor the following conditions associated with immune regulation and inflammation: autoimmune and inflammatory diseases, cancer, allergic and asthma conditions, and more. Essential for assessing Cytokine Release Syndrome (CRS), a critical condition resulting from the intense immune activation triggered by CAR-T cell therapy.
For more information on indications and other details, please click on this test .
Reference intervals available for PLASMA-EDTA, SERUM, and CSF samples.
Indications: Use this test when identifying relevant therapy targets, mechanism of disease is unknown, arthritis, macrophage activation syndrome (MAS), Hemophagocytic lymphohistiocytosis (HLH), sepsis / toxic shock, necrotizing fasciitis, admitted meningitis, admitted pneumonia, kawasaki syndrome, prolonged or periodic fever, severe or chronic inflammation, organ dysfunction.
For more information on indications and other details, please click on this test.
Reference intervals available for PLASMA-EDTA and CSF samples.
Indications: Use this test to identify relevant therapy targets, determine disease mechanisms, and diagnose or monitor the following conditions associated with complement system activation, regulation, and dysfunction: autoimmune diseases, infectious diseases, complement deficiencies, etc
For more information on indications and other details, please click on this test.
Reference intervals available for PLASMA-EDTA samples.
Indications: Use this test for acute phase inflammatory detection, chronic inflammatory diseases.
Reference intervals available for PLASMA-EDTA and CSF (SAA only) samples.
Indications: Use this test to identify relevant therapy targets, determine disease mechanisms, and diagnose or monitor the following conditions associated with vascular health, coagulation, and inflammation: thrombotic disorders, cardiovascular diseases, inflammatory diseases, sepsis and critical illness, and chronic kidney disease (CKD).
For more information on indications and details, please click on this test.
Reference intervals available for PLASMA-EDTA samples.
Indications: : Use this panel to investigate dysfunctions in vascular and endothelial integrity, coagulation, and inflammation. The panel consists of circulating factors that may suggest abnormalities in angiogenesis (a response to persistent vascular injury), coagulation, vascular function and inflammatory responses, which are thought to be key features of long COVID pathogenesis.
For more information on indications and other details, please click on this test.
Reference intervals available for PLASMA-EDTA samples.
Indications: Use this test to assess abnormalities of angiogenesis in cancer, autoimmune diseases, cardiovascular disease, or other chronic inflammatory conditions.
For more information on indications and other details, please click on this test .
Reference intervals available for PLASMA-EDTA samples.
Indications: Use this test to assess the interferon response in viral infections, autoimmune diseases, chronic inflammatory diseases and more.
For more information on indications and other details, please click on this test .
Reference intervals available for PLASMA-EDTA samples and SERUM samples.